NewGenIvf Group (NIVF) Competitors $0.52 -0.03 (-5.84%) As of 02:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. BGLC, MGRX, SSY, VSEE, DHAC, ACON, OTRK, BACK, ATIP, and BTTXShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), VSee Health (VSEE), Digital Health Acquisition (DHAC), Aclarion (ACON), Ontrak (OTRK), IMAC (BACK), ATI Physical Therapy (ATIP), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Its Competitors BioNexus Gene Lab Mangoceuticals SunLink Health Systems VSee Health Digital Health Acquisition Aclarion Ontrak IMAC ATI Physical Therapy Better Therapeutics BioNexus Gene Lab (NASDAQ:BGLC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Is BGLC or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -22.85%. NewGenIvf Group's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-22.85% -24.18% -20.14% NewGenIvf Group N/A N/A N/A Which has more volatility and risk, BGLC or NIVF? BioNexus Gene Lab has a beta of 5.08, meaning that its share price is 408% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.03, meaning that its share price is 103% less volatile than the S&P 500. Does the media prefer BGLC or NIVF? In the previous week, NewGenIvf Group had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for NewGenIvf Group and 1 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 1.87 beat NewGenIvf Group's score of 0.93 indicating that BioNexus Gene Lab is being referred to more favorably in the media. Company Overall Sentiment BioNexus Gene Lab Very Positive NewGenIvf Group Positive Do institutionals & insiders have more ownership in BGLC or NIVF? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 0.7% of BioNexus Gene Lab shares are owned by insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, BGLC or NIVF? NewGenIvf Group has lower revenue, but higher earnings than BioNexus Gene Lab. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.51M0.93-$1.60MN/AN/ANewGenIvf Group$5.43M0.41-$520KN/AN/A SummaryNewGenIvf Group beats BioNexus Gene Lab on 7 of the 11 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.23M$7.20B$5.71B$9.51BDividend YieldN/A2.81%4.60%3.99%P/E RatioN/A24.7928.0720.02Price / Sales0.4138.94459.47103.02Price / CashN/A28.2736.5558.97Price / Book-0.029.698.615.88Net Income-$520K$236.91M$3.24B$258.50M7 Day Performance-9.15%2.58%3.83%2.03%1 Month Performance-50.38%5.77%10.40%12.52%1 Year Performance-99.74%16.95%34.13%19.07% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf GroupN/A$0.52-5.8%N/A-99.7%$2.23M$5.43M0.00N/ANegative NewsGap UpBGLCBioNexus Gene Lab1.2027 of 5 stars$5.04+2.1%N/A-4.1%$9.04M$9.51M0.0030Gap DownMGRXMangoceuticals1.0601 of 5 stars$1.72-0.3%N/A-98.1%$8.87M$620K-0.373Gap UpSSYSunLink Health Systems2.5911 of 5 stars$1.21-2.0%N/A+55.2%$8.20M$31.09M8.321,376News CoverageDividend AnnouncementGap UpVSEEVSee Health1.1594 of 5 stars$1.38+0.7%$5.00+262.3%-56.1%$4.97MN/A0.00N/AGap UpDHACDigital Health AcquisitionN/A$1.35-3.6%N/A-62.8%$4.87MN/A0.002,021Gap DownACONAclarion2.9836 of 5 stars$7.30-0.3%$11,758.50+160,975.3%-99.7%$4.23M$50K0.007OTRKOntrak3.1368 of 5 stars$0.58-9.9%$24.00+4,073.9%-85.2%$2.42M$10.85M-0.04250Positive NewsBACKIMACN/A$0.06+0.8%N/A-96.7%$126K$72.05K0.00180Gap DownATIPATI Physical TherapyN/A$0.01-99.0%N/A-94.2%$44K$741.86M0.005,600BTTXBetter TherapeuticsN/AN/AN/A-66.7%$5KN/A0.0040 Related Companies and Tools Related Companies BioNexus Gene Lab Alternatives Mangoceuticals Alternatives SunLink Health Systems Alternatives VSee Health Alternatives Digital Health Acquisition Alternatives Aclarion Alternatives Ontrak Alternatives IMAC Alternatives ATI Physical Therapy Alternatives Better Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
